PATENT CLAIM ANALYSIS

Application Number: 15759487
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "020800"]

Abstract:
A method of treating dry eye disease is provided. The method includes administering to a patient in need thereof an effective amount of a pharmaceutical composition that includes an isolated clusterin or an isolated protein substantially the same as clusterin. An amount of the pharmaceutical composition immediately below the effective amount of the pharmaceutical composition has substantially no beneficial effect in treating dry eye disease.

Claim (Index 14):
The method of  claim 8 , wherein the clusterin is recombinant human clusterin.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.7
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14473622', '14971862', '15742867', '14957030', '15016623']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.781219166810648
- 35 USC 102 Novelty (BERT): 0.5211744502550076
- Combined Prediction Score: 0.7552146951550839
- Mean Citation Score: 251.653182
- Max Citation Score: 297.6904600000001
- Similarity Product: 187.60386209031583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test